[Pathogenesis of non-alcoholic fatty liver disease]

Presse Med. 2019 Dec;48(12):1468-1483. doi: 10.1016/j.lpm.2019.09.051. Epub 2019 Nov 22.
[Article in French]

Abstract

Non-Alcoholic Fatty Liver Disease (NAFLD) is a complex chronic disease resulting from an interaction between genetic and environmental factors. The phenotype and pathophysiology of NAFLD is heterogeneous. NAFLD is a continuum of histological lesions of the liver from steatosis, Non-Alcoholic SteatoHepatitis (NASH), NASH with fibrosis, cirrhosis to hepatocellular carcinoma. The pathophysiology encompasses a dysfunction in fatty tissue (sub-cutaneous and visceral) associated with insulin-resistance and metabolic inflammation. NAFLD is a "multi-systemic" disease. Reciprocal and aggravating interactions exist between NAFLD, cardiovascular anomalies and diabetes. The understanding of the mechanisms responsible for NAFLD allows the identification of potential novel therapeutic targets.

Publication types

  • Review

MeSH terms

  • Adipose Tissue / pathology
  • Alcohol Drinking / adverse effects
  • Alcohol Drinking / epidemiology
  • Epigenesis, Genetic / physiology
  • Genetic Predisposition to Disease
  • Humans
  • Inflammation / complications
  • Inflammation / diagnosis
  • Inflammation / epidemiology
  • Liver / pathology
  • Microbiota / physiology
  • Non-alcoholic Fatty Liver Disease / diagnosis
  • Non-alcoholic Fatty Liver Disease / epidemiology
  • Non-alcoholic Fatty Liver Disease / etiology*